Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Truist Maintains Buy Rating on Nurix Therapeutics, Keeps $33 Target
Truist Securities maintained its Buy rating and $33 price target on Nurix Therapeutics. The target implies 48.9% upside from the Oct. 12 close of $22.16.